This inventor holds 37 USPTO granted patents, primarily in Pharmaceuticals Development. Top assignees: Hoechst Aktiengesellschaft, Aventis Pharma Deutschland, Gmbh, Aventis Research & Technologies Gmbh & Co Kg. Active years: 1988-2008.
Location History:
- late of Darmstadt, DE (2003)
- Darmstadt, DE (1988 - 2008)
Company Filing History:
26 out of 6,705 
3 out of 330 
3 out of 62 
Years Active: 1988-2008
Areas of Expertise:
Title: Robert R. Bartlett: A Pioneer in Pharmaceutical Innovations
Introduction
Robert R. Bartlett, a notable inventor based in Darmstadt, Germany, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 37 patents. His work primarily focuses on developing innovative solutions for the treatment of organ transplant rejection reactions and combating immunological and cancerous diseases.
Latest Patents
Among his latest innovations, Bartlett has patented formulations designed for the treatment of rejection reactions in organ transplantation. This includes the use of compounds described as formulae alongside physiologically tolerable salts. Moreover, he has created a solid composition that combines 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide with N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonic acid amide, which is suitable for treating various immunological and cancerous conditions. These groundbreaking formulations underscore his commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Throughout his career, Bartlett has aligned himself with esteemed organizations, most notably Hoechst Aktiengesellschaft and Aventis Pharma Deutschland GmbH. His tenure at these companies has provided him with the foundational knowledge and resources to develop his prominent inventions, significantly impacting the pharmaceutical landscape.
Collaborations
Robert R. Bartlett's innovative journey has been bolstered by notable collaborations with fellow professionals such as Rudolf Schleyerbach and Klaus U. Weithmann. These partnerships have facilitated the exchange of ideas and advancements in their shared pursuit of medical innovation.
Conclusion
With a wealth of patents and a notable career in the pharmaceutical industry, Robert R. Bartlett exemplifies the spirit of innovation. His dedication to developing essential treatments for complex medical issues highlights his significant role as an inventor in the pharmaceutical sector. As the landscape of medicine continues to evolve, Bartlett’s contributions will undoubtedly pave the way for future breakthroughs.